FDA 510(k)

EASYMAX タグ自己監視血糖システム

K番号: K201258 · 2021-09-01

決定日2021-09-01

製品コードNBW

諮問委員会CH 当社の医療機器は、FDA（米国食品医薬品局）の規制に従って製造・販売されています。製品は、510(k)通知書およびPMA（プレマーケティング評価）を通じて承認を受けています。臨床試験情報は、NCT（臨床試験登録番号）およびPMID（PubMed ID）で確認できます。詳細については、以下のURLをご参照ください。 [URL]

決定大幅同等

医療機器の概要

EASYMAX Tag Self-Monitoring Blood Glucose System is the device name listed in this FDA 510(k) record. The listed applicant is Eps Bio Technology Corp.. It received FDA 510(k) clearance on 2021-09-01 under 510(k) number K201258. The device is classified under product code NBW. It was reviewed by the CH advisory panel. Product code NBW falls under the category of OB/GYN, which includes obstetric and gynecological diagnostic devices. Devices in this category are subject to specific FDA regulatory requirements. FDA Decision: Substantially Equivalent.

よくある質問

What is the EASYMAX Tag Self-Monitoring Blood Glucose System?

EASYMAX Tag Self-Monitoring Blood Glucose System is a medical device that received FDA 510(k) clearance on 2021-09-01. The listed applicant is Eps Bio Technology Corp.. The 510(k) number is K201258.

When did EASYMAX Tag Self-Monitoring Blood Glucose System receive FDA 510(k) clearance?

EASYMAX Tag Self-Monitoring Blood Glucose System received FDA 510(k) clearance on 2021-09-01, under 510(k) number K201258.

Who is the listed applicant for EASYMAX Tag Self-Monitoring Blood Glucose System?

The FDA 510(k) record lists Eps Bio Technology Corp. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for EASYMAX Tag Self-Monitoring Blood Glucose System?

The FDA product code for EASYMAX Tag Self-Monitoring Blood Glucose System is NBW. This falls under the OB/GYN category.

申請者としてEps Bio Technology Corp.を記載するその他の記録

K190189MDT2 BLE 自動監視血糖システム K182057EasyMax BT 自動監視血糖システム

公式ソース

FDAデータベースで見る →

データはFDA Open APIから取得しています。最新かつ権威ある情報については、常に公式レコードを参照してください。